Loading...
6493 logo

Ttbio Corp.TPEX:6493 Stock Report

Market Cap NT$811.4m
Share Price
n/a
1Y45.2%
7D6.1%
1D0.7%
Portfolio Value
View

Ttbio Corp.

TPEX:6493 Stock Report

Market Cap: NT$811.4m

Ttbio (6493) Stock Overview

Manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and the United States. More details

6493 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

6493 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Ttbio Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Ttbio
Historical stock prices
Current Share PriceNT$27.00
52 Week HighNT$80.00
52 Week LowNT$17.40
Beta0.65
1 Month Change-5.59%
3 Month Change6.72%
1 Year Change45.16%
3 Year Change-1.64%
5 Year Change4.65%
Change since IPO-45.45%

Recent News & Updates

Recent updates

Analysis Article Apr 30

Here's Why Ttbio (GTSM:6493) Can Afford Some Debt

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article Mar 31

Should Ttbio Corp. (GTSM:6493) Be Part Of Your Dividend Portfolio?

Is Ttbio Corp. ( GTSM:6493 ) a good dividend stock? How can we tell? Dividend paying companies with growing earnings...
Analysis Article Feb 03

Will Ttbio's (GTSM:6493) Growth In ROCE Persist?

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? In a perfect world...
Analysis Article Dec 22

Ttbio (GTSM:6493) Is Growing Earnings But Are They A Good Guide?

Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. Having said that...
Analysis Article Dec 03

Ttbio Corp.'s (GTSM:6493) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

It is hard to get excited after looking at Ttbio's (GTSM:6493) recent performance, when its stock has declined 5.8...
Analysis Article Nov 18

Should Ttbio Corp. (GTSM:6493) Be Part Of Your Dividend Portfolio?

Today we'll take a closer look at Ttbio Corp. (GTSM:6493) from a dividend investor's perspective. Owning a strong...

Shareholder Returns

6493TW Medical EquipmentTW Market
7D6.1%4.3%0.5%
1Y45.2%-26.2%103.9%

Return vs Industry: 6493 exceeded the TW Medical Equipment industry which returned -26.2% over the past year.

Return vs Market: 6493 underperformed the TW Market which returned 103.9% over the past year.

Price Volatility

Is 6493's price volatile compared to industry and market?
6493 volatility
6493 Average Weekly Movement11.4%
Medical Equipment Industry Average Movement4.4%
Market Average Movement6.4%
10% most volatile stocks in TW Market12.0%
10% least volatile stocks in TW Market2.6%

Stable Share Price: 6493's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: 6493's weekly volatility has decreased from 17% to 11% over the past year, but is still higher than 75% of TW stocks.

About the Company

FoundedEmployeesCEOWebsite
2012138Sheng Jie Suwww.ttbio.com

Ttbio Corp. manufactures, sells, and maintains medical devices under the TTBIO brand name in Taiwan and the United States. The company provides high and low-speed hand piece products, dental spare parts, service rotors, maintenance units, electric hand piece systems, and precision-machined components. It serves various industries, including medical, automotive, aerospace, security, computer components, maintenance parts, and custom machining.

Ttbio Corp. Fundamentals Summary

How do Ttbio's earnings and revenue compare to its market cap?
6493 fundamental statistics
Market capNT$811.35m
Earnings (TTM)-NT$21.30m
Revenue (TTM)NT$398.88m
2.0x
P/S Ratio
-38.1x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6493 income statement (TTM)
RevenueNT$398.88m
Cost of RevenueNT$328.54m
Gross ProfitNT$70.34m
Other ExpensesNT$91.64m
Earnings-NT$21.30m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.71
Gross Margin17.63%
Net Profit Margin-5.34%
Debt/Equity Ratio31.3%

How did 6493 perform over the long term?

See historical performance and comparison

Dividends

0.9%
Current Dividend Yield
-59%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/25 17:20
End of Day Share Price 2026/06/25 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ttbio Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.